Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed EPS (Basic) for 6 consecutive years, with -$0.28 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 28.21% to -$0.28 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.59 through Dec 2025, up 3.64% year-over-year, with the annual reading at -$1.59 for FY2025, 3.64% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.28 at Caribou Biosciences, up from -$0.3 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.12 in Q3 2023, with the low at -$1.39 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$0.5, with a median of -$0.44 recorded in 2022.
  • Peak annual rise in EPS (Basic) hit 81.55% in 2021, while the deepest fall reached 531.82% in 2021.
  • Over 5 years, EPS (Basic) stood at -$0.31 in 2021, then tumbled by 45.16% to -$0.45 in 2022, then grew by 11.11% to -$0.4 in 2023, then grew by 2.5% to -$0.39 in 2024, then grew by 28.21% to -$0.28 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.28, -$0.3, and -$0.58 for Q4 2025, Q3 2025, and Q2 2025 respectively.